Xencor, Inc. (XNCR)
23.62
-0.38
(-1.58%)
USD |
NASDAQ |
Oct 16, 10:47
Xencor SG&A Expense (TTM) : 65.28M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 65.28M |
| March 31, 2026 | 64.02M |
| December 31, 2025 | 63.64M |
| September 30, 2025 | 61.52M |
| June 30, 2025 | 62.13M |
| March 31, 2025 | 64.76M |
| December 31, 2024 | 61.22M |
| September 30, 2024 | 61.57M |
| June 30, 2024 | 59.30M |
| March 31, 2024 | 53.01M |
| December 31, 2023 | 53.17M |
| September 30, 2023 | 50.65M |
| June 30, 2023 | 50.53M |
| March 31, 2023 | 50.16M |
| December 31, 2022 | 47.49M |
| September 30, 2022 | 46.11M |
| June 30, 2022 | 44.11M |
| March 31, 2022 | 41.88M |
| December 31, 2021 | 38.84M |
| September 30, 2021 | 35.06M |
| June 30, 2021 | 32.33M |
| March 31, 2021 | 30.70M |
| December 31, 2020 | 29.69M |
| September 30, 2020 | 28.84M |
| June 30, 2020 | 27.46M |
| Date | Value |
|---|---|
| March 31, 2020 | 25.99M |
| December 31, 2019 | 24.28M |
| September 30, 2019 | 23.05M |
| June 30, 2019 | 24.22M |
| March 31, 2019 | 23.42M |
| December 31, 2018 | 22.47M |
| September 30, 2018 | 21.38M |
| June 30, 2018 | 18.12M |
| March 31, 2018 | 17.25M |
| December 31, 2017 | 17.50M |
| September 30, 2017 | 16.18M |
| June 30, 2017 | 15.02M |
| March 31, 2017 | 13.97M |
| December 31, 2016 | 13.11M |
| September 30, 2016 | 13.44M |
| June 30, 2016 | 13.66M |
| March 31, 2016 | 13.15M |
| December 31, 2015 | 11.96M |
| September 30, 2015 | 10.48M |
| June 30, 2015 | 9.432M |
| March 31, 2015 | 8.502M |
| December 31, 2014 | 7.461M |
| September 30, 2014 | 6.809M |
| June 30, 2014 | 5.469M |
| March 31, 2014 | 4.88M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 64.55M |
| UroGen Pharma Ltd. | 176.85M |
| MeiraGTx Holdings Plc | 52.16M |
| IDEAYA Biosciences, Inc. | 77.07M |
| Iovance Biotherapeutics, Inc. | 149.18M |